Another example is using epidermal growth factor receptor (EGFR) inhibitors successfully to treat lung cancers that harbor mutant EGFR, also using BRAF inhibitors to treat the melanomas carrying mutated BRAF (8–11). The gene discussed is BRAF; the disease is lung carcinoma.